Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02554383 · ClinicalTrials.gov registry record · Phase 3

Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?

A Phase 3 study, sponsored by Nader Shaikh.

Completed
Registry status
Phase 3
Development phase
515
Enrollment target

NCT02554383: Completed Phase 3 study, sponsored by Nader Shaikh.

NCT02554383 is a Phase 3 study that has completed, run by Nader Shaikh. The registered enrollment target is 515 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02554383, a Phase 3 study, has completed, sponsored by Nader Shaikh.

COMPLETED
Registry status
Phase 3
Development phase
515 participants
Enrollment target

Study Summary

The objective of this trial is to determine whether certain subgroups of children with acute sinusitis exist in whom antibiotic therapy can be appropriately withheld.

Primary Outcome

The Pediatric Rhinosinusitis Symptom Scale (PRSS) is a 8 item scale assessing symptoms of sinusitis. Parents are asked how their child has been doing over the last 24 hours by rating each of 8 symptoms - stuffy nose, runny nose, daytime cough, tiredness, irritability, trouble breathing through the nose, nighttime cough \& trouble sleeping - as none, almost none, a little, some, a lot \& an extreme amount with respective scores of 0, 1, 2, 3, 4 \& 5. The 8 ratings were summed to obtain a PRSS sco

Interventions

  • DRUG Placebo
  • DRUG Amoxicillin-clavulanate

Trial Details

FieldValue
Enrollment Target 515 participants
Start Date 2016-02
Est. Completion 2023-03-09
Phase Phase 3
Nader Shaikh

3 total trials

What the finished NCT02554383 record still lists

NCT02554383 is an interventional study that assigns participants to a tested intervention. The registered 515 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02554383 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02554383 about?

NCT02554383 is a clinical study titled "Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?". The objective of this trial is to determine whether certain subgroups of children with acute sinusitis exist in whom antibiotic therapy can be appropriately withheld.

What is the current status of trial NCT02554383?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 515 participants. The study started on 2016-02. Estimated completion is 2023-03-09.

What interventions are being tested in trial NCT02554383?

The interventions under investigation include: Placebo (DRUG), Amoxicillin-clavulanate (DRUG).

Who is sponsoring clinical trial NCT02554383?

This trial is sponsored by Nader Shaikh, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02554383's enrollment target sits among peer trials

515 724th of 2000 higher than 1,277 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05577819 · 515 participants · NA

    Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

  • NCT06804837 · 515 participants · NA

    Implement and Test Visual Consent Template and Process

  • NCT05933083 · 516 participants · NA

    MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

  • NCT05691244 · 514 participants · Phase 3

    Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02554383, the US trial registry maintained by the National Library of Medicine. NCT02554383 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.